Aptus Pharma discloses non-applicability of SEBI LODR Regulation 24A due to its SME Exchange listing.
The company cites Regulation 15(2) as the basis for exemption from submitting the Annual Secretarial Compliance Report.
Disclosure is a formal communication to BSE for record-keeping purposes regarding corporate governance compliance.